Young carer who unwittingly breached allowance rules forced to repay £2,000

A young carer who had looked after her disabled mother from the age of eight was forced to repay more than £2,000 when she unwittingly breached carer's allowance benefit earnings rules after joining a government youth employment scheme.
Rose Jones, 22, said she was twice wrongly advised by her jobcentre work coach that her wages earned under the Kickstart scheme would not affect her eligibility for carer's allowance.
Less than a year after she completed the six-month scheme, under which the Department for Work and Pensions (DWP) paid her wages, she received a demand from the DWP demanding she pay back £2,145 of overpaid benefits.
'I was shocked when the letter arrived – it came on my 20th birthday – and I really didn't know what to do. I thought it was a mistake because my work coach had told me it was fine. It was a really scary letter to receive,' Jones said.
The case is the latest in a stream of carer's allowance injustices highlighted by a year- long Guardian investigation and a relatively rare case involving a young carer – most unpaid carers are much older adults.
At least 144,000 UK carers are repaying more than £250m in earnings-related carer's allowance overpayments caused by what MPs said were 'human mistakes' on the part of carers and repeated DWP administrative and policy failures. Thousands of carers have been prosecuted and millions of pounds of public money wasted.
The government last year vowed to reform aspects of carer's allowance after widespread public outrage. It commissioned an independent review of carer's allowance overpayments which is expected to report to ministers in July.
Jones began caring for her mother, who has physical and mental disabilities, at the age of eight, helping around the house and with shopping, looking out for her safety, and accompanying her to hospital appointments.
Being a carer affected her childhood and education, she said: 'I was always quite hesitant to be away from my mum. I'd worry about her all the time when I was at school and struggle to focus. I wouldn't want to go on sleepovers at friends' houses.'
When she turned 16 she started to claim carer's allowance and it was only when she took up a place in 2021 on the DWP's Kickstart scheme aimed at young people at risk of long term unemployment, introduced during Covid in 2020, that it became an issue.
Jones said: 'Before I'd accepted the job [though the Kickstart scheme] I told him [the job coach] I was on carer's allowance and I told him the exact amounts I'd be on and that I'd be working from home so I'd be doing the same amount of caring as always.
'He assured me that he was confident that my carer's allowance would not be affected. I asked him a couple of times, not just one phone call. I checked again after a couple of months once I had started earning my wage, and he reassured me, so I thought at this point everything was fine.'
The demand, when it came, felt massively unjust. 'I'd been told by the work coach it was fine. I'd been a carer for my mum all my teenage years and felt my experiences had just been disregarded.'
Under Kickstart, the DWP paid employers £1,500 a month towards wages and training costs, with participants guaranteed to be paid the equivalent of 25 hours a week at the national minimum wage, in Jones's case £164 a week, or £656 a month.
Jones was taken on as a digital marketing assistant by a local firm and under carer's allowance rules was allowed to earn up to £128 a week on top of her carer duties, equivalent to 19.5 hours at the minimum wage for 18- to 20-year-olds.
Because she had unwittingly breached the weekly earnings limit, carer's allowance rules meant she forfeited her £67.60 carer's allowance. This 'cliff edge' rule meant had she gone even £1 a week over the limit for six months she would have had to repay over £2,000.
Sign up to First Edition
Our morning email breaks down the key stories of the day, telling you what's happening and why it matters
after newsletter promotion
Jones said she was frustrated by different branches of the DWP – the jobcentre, the employment section and the carer's allowance unit – which did not seem to be clear on the rules and had not routinely shared information about her case.
She was also shocked that the DWP had known about the earnings breach but had waited months before alerting her, allowing a debt to accrue that will take her years to repay. 'It's left me with a bit of distrust towards the DWP,' she said.
Emily Holzhausen, the director of policy at Carers UK, said: 'It's devastating to see a young person who has had a more challenging start in life be badly let down by the DWP.
'It's not the first time that hard-pressed carers have been given the wrong information by people working for the DWP; the very people they trust to get the rules about benefits and entitlements right.
'The fact that the DWP's computer systems don't speak to each other have left many unpaid carers with unacceptable overpayments – despite the DWP having information that could have been used to stop them earlier.'
A DWP spokesperson said: 'We understand the huge difference carers make as well as the struggles so many face.
'The carer's allowance overpayment rate is now the lowest on record and we are increasing funding and bringing in more staff to check 100% of alerts to help prevent carers falling into debt.
'But we want to go further, that's why we've launched an independent review of carer's allowance to explore how earnings-related overpayments have happened and what changes can be made.'

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

The Independent

19 minutes ago

• The Independent

Weight loss pill shows promise in new trial

A new weight loss medication, which can be offered by injection or tablet, can help patients lose a significant amount weight, studies suggest. An early study have found that people who received higher doses of amycretin as a weekly jab lost 24.3% of their body weight after 36 weeks of treatment. And initial trials assessing a tablet form of the drug also showed promising results, with patients taking daily tablets losing an average of 13.1% of their body weight after 12 weeks. Weight loss jabs have been hailed as transformative by NHS leaders. But injections come with additional work for over-stretched health services so tablet forms of medication may offer a new hope for the millions of people looking to lose weight. It has been estimated that around 1.5 million Britons are having weight loss jabs, which have been either prescribed through specialist weight loss services or private prescriptions. GPs will be able to dish out that jabs from next week. Amycretin, made by Novo Nordisk, helps to control blood sugar and appetite by targeting two specific receptors in the body – GLP-1 and the amylin receptor. An early trial in 125 adults testing weekly injections of amycretin, which has been published in The Lancet, found that those taking the highest dosage (60mg) lost 24.3% after 36 weeks of treatment. It also showed signs in improving blood sugar levels. Side effects included nausea and vomiting and were mostly mild to moderate and resolved by the end of treatment. 'These phase 1b/2a data support the potential of once-weekly subcutaneous amycretin as a therapeutic for people living with overweight or obesity,' the authors wrote. 'Amycretin appeared safe and tolerable, and there were significant reductions in body weight after 36 weeks of treatment.' The second early trial, published in the same journal, assessed amycretin in tablet form in 144 people over 12 weeks. There were mild to moderate side effects including loss of appetite, nausea and vomiting. Researchers found that people taking the highest dose of 100mg per day, lost 13.1% of their body weight over four months. The authors wrote: 'Amycretin effectively lowered body weight and improved metabolic and glycaemic parameters in people with overweight or obesity. 'Longer studies with more participants are warranted for evaluation of the safety and efficacy of amycretin in individuals living with obesity and type 2 diabetes, and to optimise the dosing regimen.' The studies were also presented at the American Diabetes Association's Scientific Sessions in Chicago, in the US. It comes as a separate study, which was published at the same meeting, examined the effects of weight loss jab Wegovy at higher doses. Researchers found that giving patients 7.2mg of Wegovy, also known as semaglutide, once a week led to an average weight loss of 20.7%, with a third of participants losing 25% or more of their body weight after 72 weeks.

Daily Mail​

41 minutes ago

• Daily Mail​

Erectile dysfunction drug Viagra has surprise new health benefit, scientists find - offering new hope to 3million ageing Britons

A surprising new health benefit has emerged from the sex drug Viagra - which means three million ageing Britons can now also enjoy a harder skull. The little blue tablet was found to increase the production of vital bone cells, preventing back pain and fractures in old age. Sildenafil - also known as Viagra - can help human stem cells transform into osteoblasts which help the human skeleton regenerate as it is completely replaced roughly once every 10 years. As humans get older, they lose more bone than is built, increasing the risk of breaks or osteoporosis, which makes bones brittle and painful. Follow-up tests on mice by Peking University also suggested a prevention of bone loss. Dr Menglong Hu and Dr Likun Wu told MailOnline: 'Our findings offer new insights into the physiological effects of the medicine. 'Sildenafil enhanced stem cell osteogenic differentiation and inhibited bone loss — it may usefully treat osteoporosis.' Viagra was invented as a heart drug in the 1980s before being found to help with erectile dysfunction. Some studies suggest it may also help reduce the risk of dementia. However, the have been cautions over the years that the drug could have some negative side effects, in particular if taken too much. A large quantity of the drug could result in a painful, 'uncomfortably and disproportionately large erection' called a priapism which could go on for hours. Some experts also found regularly taking the common drug may raise the risk of three serious eye conditions. Common side effects may include headaches, hot flushes, nausea, indigestion, dizziness and a stuffy nose. Nearly half of men between the ages of 40 and 70 suffer from erectile dysfunction in the UK - this is more than 4.5 million people. Though, reports suggest Viagra is now even becoming increasingly popular with younger individuals in their 20s and 30s. Last year, it emerged Viagra may help prevent dementia by boosting blood flow in the brain. 'This is the first trial to show that sildenafil gets into the blood vessels in the brain in people with this condition, improving blood flow and how responsive these blood vessels are,'Dr Alastair Webb, a neurologist and study author at Oxford University said.

Daily Mail​

an hour ago

• Daily Mail​

Warning over 'two tier' support for ADHD sufferers amid 'significant' rise in the use of unregulated private providers

NHS waiting lists for ADHD diagnosis and support have led to a 'significant' rise in the use of unregulated private providers, a report has said. The ADHD Taskforce, commissioned by NHS England with the support of the Government, has published an interim report calling for the system of diagnosing and managing the neurological condition to be overhauled. ADHD (attention deficit hyperactivity disorder) is characterised by patterns of restlessness, impulsivity and difficulty concentrating on one thing, with assessment and treatment typically provided by highly specialised doctors. But the report warned: 'Inability to access NHS services has led to a significant growth in the use of private providers that are not regulated, resulting in two-tier access to services, diagnosis and treatment; one for those who can pay and another for those who cannot. 'This drives health inequalities and links to disproportionate impacts and outcomes in the education and justice systems, employment and health.' Experts said waiting times for NHS ADHD services 'have escalated and are unacceptably long', with demand on services 'very likely' to continue to rise. Professor Anita Thapar, chair of the ADHD Taskforce, said: 'We need to get this right – to make sure people get early diagnosis and support.' A Department of Health and Social Care spokesman said: 'The report into the state of the NHS laid out how severe the delays have become for people waiting for an attention deficit hyperactivity disorder diagnosis.'